Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.
Chen KH, Wada M, Pinz KG, Liu H, Lin KW, Jares A, Firor AE, Shuai X, Salman H, Golightly M, Lan F, Senzel L, Leung EL, Jiang X, Ma Y.
Chen KH, et al. Among authors: ma y.
Leukemia. 2017 Oct;31(10):2151-2160. doi: 10.1038/leu.2017.8. Epub 2017 Jan 12.
Leukemia. 2017.
PMID: 28074066
Free PMC article.